Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
Public ClinicalTrials.gov record NCT00822094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase IIB, Multicenter, Randomized, Open-Label Trial Of CPX-351 (Cytarabine : Daunorubicin) Liposome Injection Versus Intensive Salvage Therapy In Adult Patients ≤ 65 Years Old With AML In First Relapse Following An Initial CR > 1 Month Duration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study investigates if CPX-351 will be a) more effective than the standard intensive salvage AML treatment and b) more tolerable than the standard intensive salvage treatment regimens. The study compares the investigational product CPX-351 vs the standard intensive salvage treatment for first relapse AML patients.
Study identification
- NCT ID
- NCT00822094
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2009 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Jan 2012 (Actual)
- Last update posted
- Nov 24, 2017
2009 – 2012
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| UCLA | Los Angeles | California | 90024 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| UC Davis Cancer Center | Sacramento | California | 95817 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Northwestern University Robert H. Lurie Comprehensive Cancer Center | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Chicago Medical Center Section of Hematology/Oncology | Chicago | Illinois | 60637 | — |
| St. Francis Cancer Center | Beech Grove | Indiana | 46107 | — |
| University of Louisville Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Maine General Medical Center Harold Alfond Center for Cancer Care | Waterville | Maine | 04901 | — |
| Johns Hopkins University | Baltimore | Maryland | 21231 | — |
| St. Louis University Medical Center | St Louis | Missouri | 63101 | — |
| The Cancer Center, Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| North Shore LIJ Center for Advanced Medicine Monter Cancer Center | Lake Success | New York | 11042 | — |
| Weil Cornell Medical Center | New York | New York | 10021 | — |
| New York Medical College | New York | New York | 10595 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Blumenthal Cancer Center/Mecklenburg Medical Group | Charlotte | North Carolina | 28204 | — |
| Duke Comprehensive Cancer Center | Durham | North Carolina | 27710 | — |
| Jewish Hospital of Cincinatti | Cincinnati | Ohio | — | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Oncology and Hematology at Lehigh Valley | Bethlehem | Pennsylvania | 18105 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| UTMB Comprehensive Cancer Center | Galveston | Texas | 77555 | — |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Joe Arrington Cancer Center | Lubbock | Texas | 79410 | — |
| Texas Tech University Health Sciences Center | Lubbock | Texas | 79415 | — |
| Cancer Therapy and Research Center at The University of TX Health Science Center | San Antonio | Texas | 78229 | — |
| Intermountain LDS Hospital | Salt Lake City | Utah | 84143 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00822094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2017 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00822094 live on ClinicalTrials.gov.